Knowledge Center

Article / Jan 01, 2012

Carcinogenic pollutants in drug manufacturing

Authors:
  • Gyorgy Szekely
  • William Heggie
  • Boerje Sellergren
Source:
Magyar Kemikusok Lapja (2012), 67(2), 34-37

A review.

Also in the Knowledge Center

Related Content

Analytical Support

Hovione has experience and capabilities to provide analytical services for Drug Substance, Drug Product and Inhalation Drug Product at all stages of development and commercial phases.

Page
Read more

Sunriser® DPI

High Performance, High-Dose Capsule DPI.

Page
Read more

API

Hovione inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more